Showing results (861-870 of 886) with videos related to
Sort By:
Pageof 89
Journal of Psychopharmacology (Oxford, England)|April 26, 2017
British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017R Hamish McAllister-Williams, David S Baldwin, Roch Cantwell, et al.Cancers|September 28, 2023
Redo Pelvic Surgery and Combined Metastectomy for Locally Recurrent Rectal Cancer with Known Oligometastatic Disease: A Multicentre ReviewCian Keogh, Niall J O'Sullivan, Hugo C Temperley, et al.Clinical and Translational Medicine|January 1, 2023
Faecal metabolite deficit, gut inflammation and diet in Parkinson's disease: Integrative analysis indicates inflammatory response syndromeAisha Augustin, Adrien Le Guennec, Chianna Umamahesan, et al.The Journal of Biological Chemistry|June 10, 2015
The Role of Phosphodiesterase 12 (PDE12) as a Negative Regulator of the Innate Immune Response and the Discovery of Antiviral InhibitorsEdgar R Wood, Randy Bledsoe, Jing Chai, et al.Journal of Medicinal Chemistry|July 6, 2016
Discovery and Characterization of a Class of Pyrazole Inhibitors of Bacterial Undecaprenyl Pyrophosphate SynthaseNestor Concha, Jianzhong Huang, Xiaopeng Bai, et al.Chembiochem : a European Journal of Chemical Biology|September 25, 2020
Characterization of Apo-Form Selective Inhibition of Indoleamine 2,3-Dioxygenase*Rodrigo F Ortiz-Meoz, Liping Wang, Rosalie Matico, et al.Cardiovascular Research|April 14, 2022
Activating P2Y1 receptors improves function in arteries with repressed autophagyJae Min Cho, Seul-Ki Park, Oh Sung Kwon, et al.The Lancet. Respiratory Medicine|March 25, 2026
Procalcitonin testing combined with NEWS2 evaluation compared with usual care based on NEWS2 for identification of sepsis and antibiotic initiation in the emergency department in England and Wales (PRONTO): a multicentre, randomised, controlled, open-label, phase 3 trialStacy Todd, Joanne Euden, Jennifer Condie, et al.Environment International|December 22, 2015
Implementing systematic review techniques in chemical risk assessment: Challenges, opportunities and recommendationsPaul Whaley, Crispin Halsall, Marlene Ågerstrand, et al.Journal of Medicinal Chemistry|July 26, 2012
Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK)Jeffrey M Axten, Jesús R Medina, Yanhong Feng, et al.Pageof 89